Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Rank in Stocks
#3680
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Share Price
$3.62
Market Cap
$4.58B
Change (1 day)
-0.16%
Change (1 year)
-53.12%
Country
CN
Trade Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Category
Healthcare
Dividend history for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (stock symbol: 603392) made a total of 4 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $1.27
Dividend yield (TTM) : 0
The sum of all dividends (adjusted for stock splits) is : $1.27
Dividend yield (TTM) : 0
Dividend payments for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392) from 2021 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.32 | 0.00% |
| 2024 | $0.32 | -55.20% |
| 2023 | $0.7143 | 399.86% |
| 2022 | $0.1429 | 62.39% |
| 2021 | $0.088 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.32 | 0.00% |
| 2024 | $0.32 | -68.00% |
| 2023 | $1.00 | 244.83% |
| 2022 | $0.29 | 16.00% |
| 2021 | $0.25 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 64.00% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
